Andrew Morris

Andrew is the Vice President, Business Development. Andrew joined ProQR in 2019, after previously holding a variety of regional and global Business Development roles in biopharma and global pharmaceutical companies, culminating in over 25 years of pharma industry experience. During his most recent 10 year tenure at Takeda, serving as Vice President of Business Development, Andrew led and executed numerous M&A transactions, negotiated numerous licensing deals across a variety of therapeutic areas, and crafted strategic development initiatives at both regional and global levels. Prior to Takeda, Andrew held numerous commercial and business development leadership positions at SmithKline Beechams, Boehringer-Ingelhiem, and Invida pharmaceuticals, spanning Europe, Emerging and Global Markets. Andrew received his undergraduate degree in Physiology from Manchester University.